New Zealand remains concerned over animal health merger
Shutterstock/viewimage
New Zealand’s antitrust watchdog has reiterated its concerns that animal health company Zoetis’ proposed acquisition of Jurox will harm competition for certain pre-anesthetics and sedatives for cats and dogs.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now